Cancertope

In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results


The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE


NeoepitopesVLLVIAGYL        Click here to BLAST against human proteome
CTL Epitope
(CTLPred)
N
HLA I Alleles
(ProPred I)
HLA-A*0201, HLA-A*0205, HLA-A2, HLA-A2.1, HLA-A24, HLA-B14, HLA-B*2705, HLA-B*3701, HLA-B*3902, HLA-B*51, HLA-B*5301, HLA-B62, HLA-B7, HLA-Cw*0301, HLA-Cw*0602, MHC-Db, MHC-Db revised, MHC-Kd18
HLA I Alleles
(nHLAPred)
NA0
HLA II Alleles
(PrePred)
DRB1_0101, DRB1_0102, DRB1_0701, DRB1_0703, DRB5_0101, DRB5_01056
B_Cell_Epitope
(ABCPred)
N

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package